Categories AlphaGraphs, Earnings, Health Care

Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues

Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also exceeded Wall Street’s projection.

AbbVie Q3 2021 earnings infographic

At $3.33 per share, September-quarter adjusted earnings were higher than $2.83 per share reported in the prior-year quarter and slightly above the consensus estimates. Net income, including special items, was $3.18 billion or $1.78 per share, compared to $2.31 billion or $1.29 per share in the third quarter of 2020.

Driving the bottom-line growth, net revenues increased 11% year-over-year to $14.34 billion. Market watchers were looking for slightly slower growth.


Read management/analysts’ comments on AbbVie’s Q3 results


AbbVie’s shares made modest gains on Friday morning following the earnings announcement, after closing the previous session higher.

Prior Performance

  • Abbvie Q3 2020 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Key metrics from Kroger’s (KR) Q3 2025 earnings results

The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical

Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights

Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or

HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results

Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top